Fox D A, Hussey R E, Fitzgerald K A, Bensussan A, Daley J F, Schlossman S F, Reinherz E L
J Immunol. 1985 Jan;134(1):330-5.
Recent studies have demonstrated that the 50KD T11 molecule is a surface component of a macrophage-independent alternative pathway of human T cell activation that is unrelated to the T3/Ti antigen-MHC receptor complex. Given the expression of T11 on all human thymocytes, it was of interest to determine whether they could be activated via this pathway. The triggering of T11 by monoclonal antibodies anti-T112 and anti-T113, directed at two unique epitopes on the molecule, induced IL 2 receptor expression on both T3+ and T3- thymocytes but did not induce IL 2 production. Consequently, in contrast to peripheral blood T cells, thymocytes did not proliferate in response to anti-T112 and anti-T113 in the absence of exogenous IL 2. These studies suggest that IL 2 receptor gene activation precedes IL 2 gene activation in T cell development. The ability of the alternative pathway of T cell activation to induce IL 2 receptor expression on T3- thymocytes implies that the T11 molecule may have an important role in early thymocyte ontogeny.
最近的研究表明,50KD的T11分子是人类T细胞激活的巨噬细胞非依赖替代途径的一种表面成分,该途径与T3/Ti抗原 - MHC受体复合物无关。鉴于T11在所有人类胸腺细胞上的表达,确定它们是否可以通过该途径被激活是很有意义的。针对该分子上两个独特表位的抗T112和抗T113单克隆抗体触发T11,可诱导T3 +和T3 -胸腺细胞上IL - 2受体的表达,但不诱导IL - 2的产生。因此,与外周血T细胞不同,在没有外源性IL - 2的情况下,胸腺细胞不会因抗T112和抗T113而增殖。这些研究表明,在T细胞发育过程中,IL - 2受体基因的激活先于IL - 2基因的激活。T细胞激活替代途径在T3 -胸腺细胞上诱导IL - 2受体表达的能力意味着T11分子可能在早期胸腺细胞个体发生中起重要作用。